Ponatinib in CML: Insights from the PONDEROSA Study
In the ever-evolving landscape of cancer treatment, chronic myeloid leukemia (CML) is a challenging adversary. As oncologists and clinical researchers ...
Tag: Treatment efficacy** **Açıklama:** 1. **Chronic myeloid leukemia (CML):** Makalenin temel konusu olan hastalık. 2. **Ponatinib:** Makalenin ve çalışmanın odak noktası olan ilaç/
